VELLORE CHRISTIAN MEDICAL COLLEGE FOUNDATION

VELLORE CMC FOUNDATION

CMC Alumni in the News

Dr. Alok Srivastava Presents a Promising Experimental Hemophilia Therapy at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

Fitusiran, an experimental hemophilia therapy administered through a monthly subcutaneous injection, met its primary endpoint in a phase III trial being presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. The drug dramatically reduced bleeding events, with half of those receiving it experiencing no bleeds and 85% experiencing an annualized bleed rate of three or fewer bleeds over the study period of about eight months. Dr. Alok Srivastava (Batch 1976) presented finds of this new study at the conference on December 14th, 2021. Read more here.

Other Alumni in the News

STAY IN TOUCH

Sign up for our Newsletter


By submitting this form, you are consenting to receive marketing emails from: Vellore Christian Medical College Foundation, 475 Riverside Dr., New York, NY, 10115, https://www.vellorecmc.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact